Biotech Stocks Are Already Risky -- Now There Are 3 New Headwinds to Face in 2023
Biotech investors love to take on oodles of risk in hopes of getting an outsized reward when one of their bets finally pays off. As though the odds of success weren't long enough, the industry is now shifting as a result of a trio of new headwinds.
The good news is that these issues will likely abate in the long term. But if you're interested in investing in the space anytime soon, you need to be aware of what's going on and what you can do to mitigate your exposure to these new risks. Let's take a look.
Image source: Getty Images.
Source Fool.com
